A division of the direct-to-patient telehealth company Ro, Roman provides patients access to a nationwide digital doctor's office and online pharmacy for certain men's health conditions through an integrated platform to enhance the convenience and quality of healthcare delivery.
Greenstone has been a leader in authorized generics for more than 25 years and manufactures sildenafil citrate, a prescription medicine used to treat erectile dysfunction.
The exclusive supply agreement with Roman represents Greenstone's first collaboration with a direct-to-patient telehealth company.
ED affects approximately 30m men in the US, and Viagra is one of the most counterfeited drugs in the world.
The collaboration between Roman and Greenstone, built on Pfizer's quality manufacturing standards, ensures patients have confidence in the quality and consistency of the generic sildenafil citrate they are prescribed and receive as part of their Roman treatment plan.
Under the agreement, Roman's generic sildenafil citrate offering will be sourced exclusively from Greenstone and manufactured in the same European facilities as branded Viagra - at no additional cost to members.
Digital Healthcare, including telemedicine, is a rapidly growing approach to healthcare designed to empower consumers to make better-informed decisions about their own health and provide new options for remote care.
The growth in the digital health industry is due to several demographic and economic factors, including an aging population and a shortage in primary care physicians in the US.
Ro's technology enables physicians to provide high quality care from diagnosis to the delivery of medication all on one platform.
All of the physicians on the Ro platform are licensed in the US and undergo an extensive background check and license verification process.
Ro is a complement, not a replacement, to a patient's overall care. Ro can keep a patient's in-person provider updated on their treatment plan at the patient's request to ensure continuity of care.
ED affects about 30 m men in the US ED is a medical condition often caused by an underlying condition such as heart disease, diabetes or depression.
However, studies show men are 24% less likely than women to go to a doctor over a one-year period and that only 25% of men who experience ED get treated.
The sildenafil citrate authorized generic is equivalent to the Viagra brand.
Greenstone is part of the Upjohn business and a wholly owned subsidiary of Pfizer Inc. (NYSE: PFE), offering a leading portfolio of Authorized Generics.
Greenstone is one of the longest running distributors of Authorized Generics in the US across a broad range of therapeutic areas. Greenstone is committed to quality, value and excellence in everything we do, and dedicated to the goal of helping patients live healthier lives.
UroGen's UGN-103 IND accepted by FDA for bladder cancer treatment
MaaT Pharma reveals positive 18-month data for MaaT013 in GI-aGvHD
Innate Pharma advances Sanofi-developed NK cell engager to Phase 2 for blood cancer patients
Soligenix receives orphan drug designation from FDA for active ingredient in SuVax
Candel Therapeutics granted FDA Orphan Drug Designation for CAN-2409 in pancreatic cancer treatment
Lipogems completes patient enrolment in ARISE I US FDA IDE study
Amylyx Pharmaceuticals' AMX0035 shows promising impact on Wolfram syndrome symptoms
Roche attains CE Mark for first companion diagnostic for HER2-low metastatic breast cancer
Cadrenal Therapeutics' tecarfarin receives US FDA Orphan Drug Designation
BioCity Biopharma's BC2027 Phase one study IND application receives US FDA approval
Seres Therapeutics completes patient enrollment for SER-155 Phase 1B trial